Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |